Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page
- ChecktodayChange DetectedRevision updated to v3.3.4 from v3.3.3; no substantive content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedIntroduced a centralized Locations section with state-by-state site listings and bumped the revision to v3.3.3, replacing the previous per-state location subsections.SummaryDifference1%

- Check36 days agoChange DetectedMajor study details such as objectives, endpoints, eligibility criteria, and enrollment appear unchanged; only formatting tweaks and a timestamp update are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedNon-significant changes observed: the page's update timestamp was refreshed and minor layout adjustments were made, with no changes to eligibility, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRemoved the government funding status notice from the page, which previously directed users to opm.gov for operating status updates. No trial content, eligibility criteria, or results were modified.SummaryDifference0.3%

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.